A detailed history of Sbi Securities Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 21,699 shares of MRNA stock, worth $556,796. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,699
Previous 19,561 10.93%
Holding current value
$556,796
Previous $555 Million 7.96%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$23.65 - $28.54 $50,563 - $61,018
2,138 Added 10.93%
21,699 $599 Million
Q1 2025

May 01, 2025

BUY
$28.35 - $47.53 $42,581 - $71,390
1,502 Added 8.32%
19,561 $555 Million
Q4 2024

Feb 05, 2025

BUY
$36.85 - $63.93 $665,474 - $1.15 Million
18,059 New
18,059 $751 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.